These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31621813)

  • 41. Surgical treatment of amyloidosis of the vitreous.
    Kasner D; Miller GR; Taylor WH; Sever RJ; Norton EW
    Trans Am Acad Ophthalmol Otolaryngol; 1968; 72(3):410-8. PubMed ID: 5659223
    [No Abstract]   [Full Text] [Related]  

  • 42. Deposits on Retinal Surface Seen on OCT in Ocular Amyloidosis.
    Kakihara S; Hirano T; Matsuda Y; Takano D; Imai A; Miyahara T; Murata T
    Ophthalmol Retina; 2021 Oct; 5(10):1005-1008. PubMed ID: 33422693
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytodiagnosis and protein typing of amyloid from a vitreous washing: initial diagnostic workup of hereditary amyloidosis.
    Coppock JD; Dusenbery AC; Elghawy O; Fellenstein LA; Frierson HF; Shildkrot Y
    J Am Soc Cytopathol; 2020; 9(3):173-176. PubMed ID: 32113804
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Considering amyloidosis in patients with clinically unresponsive vitreous inflammation (Oculoleptomeningeal amyloidosis in 3 individuals with transthyretin variant Tyr69His. Vol. 44[3]).
    Roe RH; Cunningham ET
    Can J Ophthalmol; 2010 Feb; 45(1):81. PubMed ID: 20130721
    [No Abstract]   [Full Text] [Related]  

  • 45. Vitreous amyloidosis without systemic or familial involvement.
    Salvador F; Mateo C; Alegre J; Reventos A; García-Arumi J; Corcostegui B
    Int Ophthalmol; 1993-1994; 17(6):355-7. PubMed ID: 8063479
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Role of vitrectomy in suspected vitreous amyloidosis].
    Morice C; Dutheil C; Rougier MB; Delyfer MN; Korobelnik JF; Léger F
    J Fr Ophtalmol; 2019 Dec; 42(10):e463-e464. PubMed ID: 31253434
    [No Abstract]   [Full Text] [Related]  

  • 47. Surgery for floaters.
    Mura M; Engelbrecht LA; de Smet MD; Papadaki TG; van den Berg TJ; Tan HS
    Ophthalmology; 2011 Sep; 118(9):1894-1894.e1. PubMed ID: 21889665
    [No Abstract]   [Full Text] [Related]  

  • 48. Panretinal photocoagulation in the treatment of vitreoretinal amyloidosis.
    Baum MD; Weiss HS; Sanders RJ
    Arch Ophthalmol; 1998 Nov; 116(11):1534. PubMed ID: 9823364
    [No Abstract]   [Full Text] [Related]  

  • 49. Primary familial amyloidosis.
    Wong VG; McFarlin DE
    Arch Ophthalmol; 1967 Aug; 78(2):208-13. PubMed ID: 4952599
    [No Abstract]   [Full Text] [Related]  

  • 50. Vitreous amyloidosis in alanine 71 transthyretin mutation.
    Zambarakji HJ; Charteris DG; Ayliffe W; Luthert PJ; Schon F; Hawkins PN
    Br J Ophthalmol; 2005 Jun; 89(6):773-4. PubMed ID: 15923520
    [No Abstract]   [Full Text] [Related]  

  • 51. [Primary vitreous amyloidosis. Apropos of a case with ultrastructural study].
    Goberville M; Korobelnik JF; D'Hermies F; Cotinat J; Savoldelli M; Chauvaud D; Pouliquen Y
    J Fr Ophtalmol; 1994; 17(6-7):418-22. PubMed ID: 8083492
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ocular Manifestations of Familial Transthyretin Amyloidosis.
    Reynolds MM; Veverka KK; Gertz MA; Dispenzieri A; Zeldenrust SR; Leung N; Pulido JS
    Am J Ophthalmol; 2017 Nov; 183():156-162. PubMed ID: 28911993
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Familial vitreous amyloidosis resulting from transthyretin variant Gly83Arg.
    Xie B; Cai SJ; Jiang M; Li H; Su G
    Acta Ophthalmol; 2017 Sep; 95(6):e520-e521. PubMed ID: 28266151
    [No Abstract]   [Full Text] [Related]  

  • 54. Transthyretin amyloidosis associated with a novel variant (Trp41Leu) presenting with vitreous opacities.
    Yazaki M; Connors LH; Eagle RC; Leff SR; Skinner M; Benson MD
    Amyloid; 2002 Dec; 9(4):263-7. PubMed ID: 12557756
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterisation and management of vitreous and nerve amyloid in familial amyloid polyneuropathy due to variant transthyretin, Phe33Val.
    Gregory ME; Carey M; Hawkins PN; Banerjee S; Gillmore JD
    Br J Ophthalmol; 2008 Jan; 92(1):34-5, 142. PubMed ID: 18156374
    [No Abstract]   [Full Text] [Related]  

  • 56. Biochemical characterization of vitreous amyloid formed after liver transplantation.
    Liepnieks JJ; Phan AD; Wise RJ; Hrisomalos FN; Benson MD
    Amyloid; 2016 Jun; 23(2):136-7. PubMed ID: 27043487
    [No Abstract]   [Full Text] [Related]  

  • 57. [A familial observation of hereditary vitreal amyloidosis associated with glaucoma].
    Limon S; Rousselie F; Joseph E
    Arch Ophtalmol Rev Gen Ophtalmol; 1973; 33(6):525-8. PubMed ID: 4274542
    [No Abstract]   [Full Text] [Related]  

  • 58. Pars plana vitrectomy for vitreous amyloidosis.
    Doft BH; Machemer R; Skinner M; Buettner H; Clarkson J; Crock J; McLeod D; Michels R; Scott J; Wilson D
    Ophthalmology; 1987 Jun; 94(6):607-11. PubMed ID: 3627709
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vitrectomy for large vitreous opacity in retinitis pigmentosa.
    Hong PH; Han DP; Burke JM; Wirostko WJ
    Am J Ophthalmol; 2001 Jan; 131(1):133-4. PubMed ID: 11162992
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Role of vitrectomy in patients with a decrease in visual acuity secondary to asteroid hyalosis].
    Boissonnot M; Manic H; Balayre S; Dighiero P
    J Fr Ophtalmol; 2004 Sep; 27(7):791-4. PubMed ID: 15499277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.